Asia Pac ECM and Index Rebal, Shenton Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac ECM and Index Rebal

This Week in AI (Mar 29 – Apr 4): OpenAI Pre-IPO $122bn Fundraising; Zhipu Results; Google Gemma 4

This Week in AI (Apr 5-11): Anthropic's Mythos Is Too Dangerous; Zhipu Tops Bench on Huawei Chips

This Week in AI (Apr 12-18): Anthropic/OpenAI Rivalry Intensifies; Opus 4.7; Cerebras IPO Filing

This Week in AI (Mar 15-21): Jensen Huang Endorses OpenClaw; MiniMax/Zhipu New Model

Asia Pac IPO & Placement Research, China Biotech

DZT Research

DZT Research is an independent Asia Pacific equity specialist. Our quantitative research covers index rebalancing flows, alongside exchange data analytics accross Asia Pacific. On the equity capital markets side, we focus on Asia Pacific ECM, especially biotech and TMT. Our lead analyst is frequently cited by international media.

Equity Bottom-Up

<ul>
<li>We tracked AI models, infrastructure, and M&amp;A this week: Anthropic's accidental Mythos leak and IPO plans dominated headlines.</li>
<li>MiniMax M2.7 demand exceeded capacity; Xiaomi's MiMo-V2-Pro took #1 on OpenRouter; Stepfun launched its first subscription.</li>
<li>Moonshot AI is raising $1bn at $17-18bn pre-money ahead of a potential HK listing; Shield AI raised $2bn at $12.7bn.</li>
</ul>


We tracked AI models, infrastructure, and M&amp;A this week: Anthropic's accidental Mythos leak and IPO plans dominated headlines.
MiniMax M2.7 demand exceeded capacity; Xiaomi's MiMo-V2-Pro took #1 on OpenRouter; Stepfun launched its first subscription.
Moonshot AI is raising $1bn at $17-18bn pre-money ahead of a potential HK listing; Shield AI raised $2bn at $12.7bn.


This Week in AI (Mar 22-28): Anthropic/Moonshot Eyeing IPOs; TurboQuant Rattles Memory Stocks